Wordt geladen...
An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?
As patents on many high-selling biological medicines are expiring, non-innovator versions, such as biosimilars, may enter this multi-billion dollar market. This study aims to map patents and patent applications for innovator as well as biosimilar monoclonal antibodies in Europe, and investigates leg...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis Group
2020-01-01
|
| Reeks: | mAbs |
| Onderwerpen: | |
| Online toegang: | https://www.tandfonline.com/doi/10.1080/19420862.2020.1743517 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Wordt geladen...